Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer

To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10–1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10)...

Full description

Saved in:
Bibliographic Details
Published inJournal of Veterinary Medical Science Vol. 81; no. 2; pp. 252 - 255
Main Authors SASAI, Kazumi, YAMASHITA, Runa, SOMA, Takehisa, OHTA, Kaisaku
Format Journal Article
LanguageEnglish
Published Japan JAPANESE SOCIETY OF VETERINARY SCIENCE 2019
Japan Science and Technology Agency
The Japanese Society of Veterinary Science
Subjects
cat
Feline panleukopenia
feline panleukopenia virus
Hemagglutination inhibition
hemagglutination inhibition test
serum neutralizing test
Virology
hemagglutination inhibition test
feline panleukopenia virus
serum neutralizing test
cat
Online AccessGet full text

Cover

Abstract To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10–1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10) in 33 (62.3%) of 53 HI antibody-negative cats, and ranged <1:10–1:160. This suggests that FPV-antibody detection sensitivity of HI test is lower than SN test, and SN test is more suitable for the assessment of FPV-vaccine effect than HI test especially in cats with negative or low HI titer. SN titer was 1:32, FPV-protective threshold, or higher in all cats with HI titers of ≥1:20, suggesting it may be appropriate to set protective HI threshold at 1:20.
AbstractList To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10-1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10) in 33 (62.3%) of 53 HI antibody-negative cats, and ranged <1:10-1:160. This suggests that FPV-antibody detection sensitivity of HI test is lower than SN test, and SN test is more suitable for the assessment of FPV-vaccine effect than HI test especially in cats with negative or low HI titer. SN titer was 1:32, FPV-protective threshold, or higher in all cats with HI titers of ≥1:20, suggesting it may be appropriate to set protective HI threshold at 1:20.To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10-1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10) in 33 (62.3%) of 53 HI antibody-negative cats, and ranged <1:10-1:160. This suggests that FPV-antibody detection sensitivity of HI test is lower than SN test, and SN test is more suitable for the assessment of FPV-vaccine effect than HI test especially in cats with negative or low HI titer. SN titer was 1:32, FPV-protective threshold, or higher in all cats with HI titers of ≥1:20, suggesting it may be appropriate to set protective HI threshold at 1:20.
To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10-1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10) in 33 (62.3%) of 53 HI antibody-negative cats, and ranged <1:10-1:160. This suggests that FPV-antibody detection sensitivity of HI test is lower than SN test, and SN test is more suitable for the assessment of FPV-vaccine effect than HI test especially in cats with negative or low HI titer. SN titer was 1:32, FPV-protective threshold, or higher in all cats with HI titers of ≥1:20, suggesting it may be appropriate to set protective HI threshold at 1:20.
To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153 FPV-vaccinated cats aged ≥7 months with HI titer of <1:10–1:40, were examined for serum neutralizing (SN) antibody. SN antibody was detected (≥1:10) in 33 (62.3%) of 53 HI antibody-negative cats, and ranged <1:10–1:160. This suggests that FPV-antibody detection sensitivity of HI test is lower than SN test, and SN test is more suitable for the assessment of FPV-vaccine effect than HI test especially in cats with negative or low HI titer. SN titer was 1:32, FPV-protective threshold, or higher in all cats with HI titers of ≥1:20, suggesting it may be appropriate to set protective HI threshold at 1:20.
Author SOMA, Takehisa
SASAI, Kazumi
YAMASHITA, Runa
OHTA, Kaisaku
Author_xml – sequence: 1
  fullname: SASAI, Kazumi
  organization: Laboratory of Veterinary Internal Medicine, Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Orai-Kita, Izumisano, Osaka 598-8531, Japan
– sequence: 1
  fullname: YAMASHITA, Runa
  organization: Hana Animal Hospital, 2-28-4 Umezato, Suginami-ku, Tokyo 166-0011, Japan
– sequence: 1
  fullname: SOMA, Takehisa
  organization: Laboratory of Veterinary Internal Medicine, Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Orai-Kita, Izumisano, Osaka 598-8531, Japan
– sequence: 1
  fullname: OHTA, Kaisaku
  organization: Hana Animal Hospital, 2-28-4 Umezato, Suginami-ku, Tokyo 166-0011, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30541981$$D View this record in MEDLINE/PubMed
BookMark eNp1ks9vFCEUx4mpsdvqzbMh8eLBqcD8gotJ2_graeJFz4Rh38ywMrACs039Q_x7ZbrrxjbxAoT3-X557_HO0InzDhB6SckFZYK92-ymeEF5QaqWPUErWlZt0ValOEErImhTtKwmp-gsxg0hjFaNeIZOS1JXVHC6Qr8vXTJFD9Y4wFvlLMw__BacUXhnwhxxhDBP2MGcgrLml3EDVlnS-fUdTiZBwMbhtZ8gJqOxViniW5NGnEbIqkElswPsA7b-Fo8wqWGwczIu33uXpaPpzP3xoelz9LRXNsKLw36Ovn_88O36c3Hz9dOX68ubQtcNTYXWFEgpRLXmXatAKaKgUZT0Vd00vFW8401JgPasplWtG6g0EK5r0elec03Lc_R-77uduwnWGtxSptwGM6lwJ70y8mHEmVEOfiebUtSMLAZvDgbB_5xzE-RkogZrlQM_R8loXQvSEkIy-voRuvFzcLk8yVgpGtrykmfq1b8ZHVP5-2UZeLsHdPAxBuiPCCVymQi5TISkXC4TkXH2CNcm3Xc_12Ps_0RXe9EmJjXA8QUV8idb2MOcSrYsB9ExqEcVJLjyD89I18A
CitedBy_id crossref_primary_10_3389_fmicb_2025_1501635
crossref_primary_10_1186_s12917_020_02496_z
crossref_primary_10_1186_s12896_024_00900_2
Cites_doi 10.1016/S0378-1135(96)01225-4
10.2460/javma.2004.224.61
10.1016/j.jfms.2008.05.004
10.1007/s00705-013-1914-1
10.1128/CDLI.8.3.612-615.2001
10.1016/S0195-5616(86)50139-X
10.1016/0264-410X(94)90158-9
10.2460/javma.1998.213.01.54
10.1538/expanim1978.34.3_287
10.1292/jvms1939.51.264
10.1111/j.1439-0450.1987.tb00451.x
10.2460/javma.2002.220.38
10.1186/1746-6148-8-62
10.1136/vr.83.25.653
10.1016/j.tvjl.2013.12.023
10.1177/1098612X11432240
ContentType Journal Article
Copyright 2019 by the Japanese Society of Veterinary Science
Copyright Japan Science and Technology Agency Feb 2019
2019 The Japanese Society of Veterinary Science 2019
Copyright_xml – notice: 2019 by the Japanese Society of Veterinary Science
– notice: Copyright Japan Science and Technology Agency Feb 2019
– notice: 2019 The Japanese Society of Veterinary Science 2019
DBID AAYXX
CITATION
NPM
7QR
7U9
8FD
FR3
H94
M7N
P64
7X8
5PM
DOI 10.1292/jvms.18-0472
DatabaseName CrossRef
PubMed
Chemoreception Abstracts
Virology and AIDS Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Virology and AIDS Abstracts
Technology Research Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed
Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Veterinary Medicine
EISSN 1347-7439
EndPage 255
ExternalDocumentID PMC6395201
30541981
10_1292_jvms_18_0472
article_jvms_81_2_81_18_0472_article_char_en
Genre Journal Article
GroupedDBID 29L
2WC
53G
5GY
ACGFO
ACIWK
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B.T
BAWUL
CS3
DIK
DU5
E3Z
EBS
ECGQY
EJD
EYRJQ
HYE
JSF
JSH
KQ8
M48
N5S
OK1
OVT
P2P
PGMZT
RJT
RNS
RPM
RZJ
TKC
TR2
VH1
XSB
AAYXX
CITATION
NPM
7QR
7U9
8FD
FR3
H94
M7N
P64
7X8
5PM
ID FETCH-LOGICAL-c561t-cc1e03994d8b7aeaa0ae6a10f456687a8b8630e1f25145c6e4ce08c59bcfc8c13
IEDL.DBID M48
ISSN 0916-7250
1347-7439
IngestDate Thu Aug 21 17:52:16 EDT 2025
Fri Jul 11 10:30:37 EDT 2025
Mon Jun 30 11:23:16 EDT 2025
Thu Apr 03 06:57:19 EDT 2025
Tue Jul 01 04:14:35 EDT 2025
Thu Apr 24 23:08:50 EDT 2025
Wed Sep 03 06:29:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords hemagglutination inhibition test
feline panleukopenia virus
serum neutralizing test
cat
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0/deed.ja
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/)
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c561t-cc1e03994d8b7aeaa0ae6a10f456687a8b8630e1f25145c6e4ce08c59bcfc8c13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1292/jvms.18-0472
PMID 30541981
PQID 2239617838
PQPubID 2028964
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6395201
proquest_miscellaneous_2155907000
proquest_journals_2239617838
pubmed_primary_30541981
crossref_primary_10_1292_jvms_18_0472
crossref_citationtrail_10_1292_jvms_18_0472
jstage_primary_article_jvms_81_2_81_18_0472_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-00-00
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 2019-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Journal of Veterinary Medical Science
PublicationTitleAlternate J. Vet. Med. Sci.
PublicationYear 2019
Publisher JAPANESE SOCIETY OF VETERINARY SCIENCE
Japan Science and Technology Agency
The Japanese Society of Veterinary Science
Publisher_xml – name: JAPANESE SOCIETY OF VETERINARY SCIENCE
– name: Japan Science and Technology Agency
– name: The Japanese Society of Veterinary Science
References 17. Povey, R. C., Koonse, H. and Hays, M. B. 1980. Immunogenicity and safety of an inactivated vaccine for the prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats. J. Am. Vet. Med. Assoc. 177: 347–350.
20. Scott, F. W., Csiza, C. K. and Gillespie, J. H. 1970. Maternally derived immunity to feline panleukopenia. J. Am. Vet. Med. Assoc. 156: 439–453.
7. Jakel, V., Cussler, K., Hanschmann, K. M., Truyen, U., König, M., Kamphuis, E. and Duchow, K. 2012. Vaccination against Feline Panleukopenia: implications from a field study in kittens. BMC Vet. Res. 8: 62.
10. Langeveld, J. P., Casal, J. I., Cortés, E., van de Wetering, G., Boshuizen, R. S., Schaaper, W. M., Dalsgaard, K. and Meloen, R. H. 1994. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12: 1473–1480.
4. Fastier, L. B. 1968. Feline panleucopenia—a serological study. Vet. Rec. 83: 653–654.
15. Mochizuki, M., Konishi, S., Ajiki, M. and Akaboshi, T. 1989. Comparison of feline parvovirus subspecific strains using monoclonal antibodies against a feline panleukopenia virus. Nippon Juigaku Zasshi 51: 264–272.
1. Appel, M. and Parrish, C. R. 1987. Canine parvovirus type 2. pp. 69–92. In: Virus Infections of Carnivores (Appel, M., ed.), Elsevier Science Publishers, Amsterdam.
8. Johnson, R. H. 1971. Serologic procedures for the study of feline panleukopenia. J. Am. Vet. Med. Assoc. 158: 2, 876.
23. Yagami, K., Furukawa, T., Fukui, M. and Hamada, H. 1985. Evaluation of tri-combinant vaccine for feline herpesvirus, calicivirus and panleukopenia virus infections in Japanese native cats. Jikken Dobutsu 34: 287–294.
18. Pratelli, A., Cavalli, A., Martella, V., Tempesta, M., Decaro, N., Carmichael, L. E. and Buonavoglia, C. 2001. Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin. Diagn. Lab. Immunol. 8: 612–615.
22. Tizard, I. and Ni, Y. 1998. Use of serologic testing to assess immune status of companion animals. J. Am. Vet. Med. Assoc. 213: 54–60.
12. Lappin, M. R., Andrews, J., Simpson, D. and Jensen, W. A. 2002. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. J. Am. Vet. Med. Assoc. 220: 38–42.
21. Tham, K. M. and Studdert, M. J. 1987. Antibody and cell mediated immune responses to an inactivated feline panleukopenia virus vaccine. Zentralbl. Veterinarmed. B. 34: 701–712.
19. Scott, F. W. 1971. Comments on feline panleukopenia biologics. J. Am. Vet. Med. Assoc. 158: 2, 910–915.
6. Horiuchi, M., Yuri, K., Soma, T., Katae, H., Nagasawa, H. and Shinagawa, M. 1996. Differentiation of vaccine virus from field isolates of feline panleukopenia virus by polymerase chain reaction and restriction fragment length polymorphism analysis. Vet. Microbiol. 53: 283–293.
13. Lappin, M. R., Veir, J. and Hawley, J. 2009. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines. J. Feline Med. Surg. 11: 159–162.
16. Mouzin, D. E., Lorenzen, M. J., Haworth, J. D. and King, V. L. 2004. Duration of serologic response to three viral antigens in cats. J. Am. Vet. Med. Assoc. 224: 61–66.
5. Greene, C. E. 2012. Feline enteric viral infections. pp. 80–91. In: Infectious Disease of the Dog and Cat (Greene, C. E., ed.), Saunders Elsevier, St. Louis.
9. King, D. A. and Croghan, D. L. 1965. Immunofluorescence of feline panleucopenia virus in cell culture: determination of immunological status of felines by serum neutralization. Can. J. Comp. Med. Vet. Sci. 29: 85–89.
11. Lappin, M. R. 2012. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine. J. Feline Med. Surg. 14: 161–164.
2. Cotmore, S. F., Agbandje-McKenna, M., Chiorini, J. A., Mukha, D. V., Pintel, D. J., Qiu, J., Soderlund-Venermo, M., Tattersall, P., Tijssen, P., Gatherer, D. and Davison, A. J. 2014. The family Parvoviridae. Arch. Virol. 159: 1239–1247.
3. Dhein, C. R. and Gorham, J. R. 1986. Host response to vaccination. Vet. Clin. North Am. Small Anim. Pract. 16: 1227–1245.
14. Mende, K., Stuetzer, B., Sauter-Louis, C., Homeier, T., Truyen, U. and Hartmann, K. 2014. Prevalence of antibodies against feline panleukopenia virus in client-owned cats in Southern Germany. Vet. J. 199: 419–423.
11
22
12
23
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
10
21
References_xml – reference: 2. Cotmore, S. F., Agbandje-McKenna, M., Chiorini, J. A., Mukha, D. V., Pintel, D. J., Qiu, J., Soderlund-Venermo, M., Tattersall, P., Tijssen, P., Gatherer, D. and Davison, A. J. 2014. The family Parvoviridae. Arch. Virol. 159: 1239–1247.
– reference: 7. Jakel, V., Cussler, K., Hanschmann, K. M., Truyen, U., König, M., Kamphuis, E. and Duchow, K. 2012. Vaccination against Feline Panleukopenia: implications from a field study in kittens. BMC Vet. Res. 8: 62.
– reference: 10. Langeveld, J. P., Casal, J. I., Cortés, E., van de Wetering, G., Boshuizen, R. S., Schaaper, W. M., Dalsgaard, K. and Meloen, R. H. 1994. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 12: 1473–1480.
– reference: 17. Povey, R. C., Koonse, H. and Hays, M. B. 1980. Immunogenicity and safety of an inactivated vaccine for the prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats. J. Am. Vet. Med. Assoc. 177: 347–350.
– reference: 16. Mouzin, D. E., Lorenzen, M. J., Haworth, J. D. and King, V. L. 2004. Duration of serologic response to three viral antigens in cats. J. Am. Vet. Med. Assoc. 224: 61–66.
– reference: 14. Mende, K., Stuetzer, B., Sauter-Louis, C., Homeier, T., Truyen, U. and Hartmann, K. 2014. Prevalence of antibodies against feline panleukopenia virus in client-owned cats in Southern Germany. Vet. J. 199: 419–423.
– reference: 21. Tham, K. M. and Studdert, M. J. 1987. Antibody and cell mediated immune responses to an inactivated feline panleukopenia virus vaccine. Zentralbl. Veterinarmed. B. 34: 701–712.
– reference: 19. Scott, F. W. 1971. Comments on feline panleukopenia biologics. J. Am. Vet. Med. Assoc. 158: 2, 910–915.
– reference: 4. Fastier, L. B. 1968. Feline panleucopenia—a serological study. Vet. Rec. 83: 653–654.
– reference: 5. Greene, C. E. 2012. Feline enteric viral infections. pp. 80–91. In: Infectious Disease of the Dog and Cat (Greene, C. E., ed.), Saunders Elsevier, St. Louis.
– reference: 12. Lappin, M. R., Andrews, J., Simpson, D. and Jensen, W. A. 2002. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. J. Am. Vet. Med. Assoc. 220: 38–42.
– reference: 13. Lappin, M. R., Veir, J. and Hawley, J. 2009. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines. J. Feline Med. Surg. 11: 159–162.
– reference: 22. Tizard, I. and Ni, Y. 1998. Use of serologic testing to assess immune status of companion animals. J. Am. Vet. Med. Assoc. 213: 54–60.
– reference: 6. Horiuchi, M., Yuri, K., Soma, T., Katae, H., Nagasawa, H. and Shinagawa, M. 1996. Differentiation of vaccine virus from field isolates of feline panleukopenia virus by polymerase chain reaction and restriction fragment length polymorphism analysis. Vet. Microbiol. 53: 283–293.
– reference: 3. Dhein, C. R. and Gorham, J. R. 1986. Host response to vaccination. Vet. Clin. North Am. Small Anim. Pract. 16: 1227–1245.
– reference: 18. Pratelli, A., Cavalli, A., Martella, V., Tempesta, M., Decaro, N., Carmichael, L. E. and Buonavoglia, C. 2001. Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin. Diagn. Lab. Immunol. 8: 612–615.
– reference: 9. King, D. A. and Croghan, D. L. 1965. Immunofluorescence of feline panleucopenia virus in cell culture: determination of immunological status of felines by serum neutralization. Can. J. Comp. Med. Vet. Sci. 29: 85–89.
– reference: 11. Lappin, M. R. 2012. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine. J. Feline Med. Surg. 14: 161–164.
– reference: 20. Scott, F. W., Csiza, C. K. and Gillespie, J. H. 1970. Maternally derived immunity to feline panleukopenia. J. Am. Vet. Med. Assoc. 156: 439–453.
– reference: 23. Yagami, K., Furukawa, T., Fukui, M. and Hamada, H. 1985. Evaluation of tri-combinant vaccine for feline herpesvirus, calicivirus and panleukopenia virus infections in Japanese native cats. Jikken Dobutsu 34: 287–294.
– reference: 8. Johnson, R. H. 1971. Serologic procedures for the study of feline panleukopenia. J. Am. Vet. Med. Assoc. 158: 2, 876.
– reference: 1. Appel, M. and Parrish, C. R. 1987. Canine parvovirus type 2. pp. 69–92. In: Virus Infections of Carnivores (Appel, M., ed.), Elsevier Science Publishers, Amsterdam.
– reference: 15. Mochizuki, M., Konishi, S., Ajiki, M. and Akaboshi, T. 1989. Comparison of feline parvovirus subspecific strains using monoclonal antibodies against a feline panleukopenia virus. Nippon Juigaku Zasshi 51: 264–272.
– ident: 6
  doi: 10.1016/S0378-1135(96)01225-4
– ident: 16
  doi: 10.2460/javma.2004.224.61
– ident: 17
– ident: 5
– ident: 13
  doi: 10.1016/j.jfms.2008.05.004
– ident: 1
– ident: 2
  doi: 10.1007/s00705-013-1914-1
– ident: 18
  doi: 10.1128/CDLI.8.3.612-615.2001
– ident: 3
  doi: 10.1016/S0195-5616(86)50139-X
– ident: 19
– ident: 10
  doi: 10.1016/0264-410X(94)90158-9
– ident: 22
  doi: 10.2460/javma.1998.213.01.54
– ident: 23
  doi: 10.1538/expanim1978.34.3_287
– ident: 15
  doi: 10.1292/jvms1939.51.264
– ident: 21
  doi: 10.1111/j.1439-0450.1987.tb00451.x
– ident: 9
– ident: 12
  doi: 10.2460/javma.2002.220.38
– ident: 7
  doi: 10.1186/1746-6148-8-62
– ident: 8
– ident: 4
  doi: 10.1136/vr.83.25.653
– ident: 14
  doi: 10.1016/j.tvjl.2013.12.023
– ident: 20
– ident: 11
  doi: 10.1177/1098612X11432240
SSID ssj0021469
Score 2.2068238
Snippet To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153...
To evaluate the accuracy of hemagglutination inhibition (HI) test as the index of feline panleukopenia virus (FPV)-protective ability, sera from 153...
SourceID pubmedcentral
proquest
pubmed
crossref
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 252
SubjectTerms cat
Feline panleukopenia
feline panleukopenia virus
Hemagglutination inhibition
hemagglutination inhibition test
serum neutralizing test
Virology
Title Anti-feline panleukopenia virus serum neutralizing antibody titer in domestic cats with the negative or low hemagglutination inhibition antibody titer
URI https://www.jstage.jst.go.jp/article/jvms/81/2/81_18-0472/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/30541981
https://www.proquest.com/docview/2239617838
https://www.proquest.com/docview/2155907000
https://pubmed.ncbi.nlm.nih.gov/PMC6395201
Volume 81
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Veterinary Medical Science, 2019, Vol.81(2), pp.252-255
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VglAvCMorpVRGghNKsbNx7AghVCGqAlpOLOotchxnm7Kb0N1NofwQfi8zeYldlQuXXDyOEs-M_Y3t-QbgudKx5Njoy9xwP0xF5BtrMXC1KTHwCeearPfx5-hkEn48ladb0Fcb7QZweW1oR_WkJovZ4c-Lq7fo8G8aboQ4eHV-OV8eCu0T8eENuIlrkiIXHYfDeQJVr25Z9_BbFK763RX4zd47cBvtP8RAXKytU7fOEapN3XUodPMy5V-r0_FduNPBSnbU2sE92HLlLux-pbsuTcItG3dn6Pfh91G5Kvyc8tAdw7lg5upv9M-FYZfFol4yNMp6zkpXN5sgv3BtYzj8RVplV6xhYWZFybJqTvwcllmzWjLazWUIJbHXtGESZ9WCzaofjChhp1Oy7nbXEbueFWlzTWzjpQ9gcvz-y7sTv6vO4FvEXCvfWuE4wpsw06kyzhhuXGQEzxGSRVoZnepoxJ3IEUGF0kYutI5rK-PU5lZbMXoI22VVusfAtMxybgOZYfQSKiVNGgYiU0YFmZQjxz142esisR11OVXQmCUUwqASE1JiInRCSvTgxSD9vaXs-Ifc61atg1TnrK2UFklAj056aKRsOJxSPNjvbSHprTZBrBVTzuVIe_BsaEaHpVMYU7qqRhk6CMaJluNvPWpNZ_iA3vg8UGtGNQgQGfh6S1mcNaTgiDQlgrm9_-75BHbwGbfbS_uwvVrU7ikCrlV6gKHGh08HjUf9AXh7M4E
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-feline+panleukopenia+virus+serum+neutralizing+antibody+titer+in+domestic+cats+with+the+negative+or+low+hemagglutination+inhibition+antibody+titer&rft.jtitle=Journal+of+veterinary+medical+science&rft.au=SOMA%2C+Takehisa&rft.au=OHTA%2C+Kaisaku&rft.au=YAMASHITA%2C+Runa&rft.au=SASAI%2C+Kazumi&rft.date=2019&rft.pub=The+Japanese+Society+of+Veterinary+Science&rft.issn=0916-7250&rft.eissn=1347-7439&rft.volume=81&rft.issue=2&rft.spage=252&rft.epage=255&rft_id=info:doi/10.1292%2Fjvms.18-0472&rft_id=info%3Apmid%2F30541981&rft.externalDocID=PMC6395201
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-7250&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-7250&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-7250&client=summon